Prospect Venture Partners logo

Prospect Venture Partners

North America, California, United States, Palo Alto

Description

Prospect Venture Partners is a Palo Alto, California based venture capital firm<br>with over $1B of capital under management.

Investor Profile

Prospect Venture Partners has made 88 investments, with 0 in the past 12 months and 20% as lead.

Stage Focus

  • Series B (34%)
  • Series A (18%)
  • Series C (17%)
  • Series D (14%)
  • Series Unknown (11%)
  • Series E (2%)
  • Post Ipo Equity (1%)
  • Series G (1%)
  • Series F (1%)

Country Focus

  • United States (99%)
  • Belgium (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Medical Device
  • Therapeutics
  • Biopharma
  • Genetics
  • Life Science
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Prospect Venture Partners frequently co-invest with?

Three Arch Partners
North America, California, United States, Portola Valley
Co-Investments: 8
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 11
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 11
Versant Ventures
North America, California, United States, Menlo Park
Co-Investments: 8
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 6
Frazier Healthcare Partners
North America, Washington, United States, Seattle
Co-Investments: 7
Highland Capital Partners
North America, Massachusetts, United States, Lexington
Co-Investments: 6
Rho Ventures
North America, New York, United States, New York
Co-Investments: 6
Venrock
North America, California, United States, Palo Alto
Co-Investments: 15
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 7

Which angels does Prospect Venture Partners often collaborate with?

SP
Europe, Germany
Shared Deals: 1
FM
North America, United States
Shared Deals: 1
SH
North America, New Hampshire, United States, Center Harbor
Shared Deals: 1

What are some of recent deals done by Prospect Venture Partners?

SentreHEART

Redwood City, California, United States

SentreHEART is a medical device company developing tissue closure solutions, offering physicians control over remotely delivered sutures.

Health CareMedicalMedical Device
Series DSep 27, 2016
Amount Raised: $35,000,000
NGM Biopharmaceuticals

South San Francisco, California, United States

NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.

BiopharmaBiotechnologyGeneticsMedical
Series DMar 23, 2015
Amount Raised: $57,500,000
Nora Therapeutics

Palo Alto, California, United States

Nora Therapeutics is a specialty biopharmaceutical company developing therapeutics to address clinical unmet needs in reproductive medicine.

BiotechnologyHealth CareMedical Device
Series BApr 17, 2014
Amount Raised: $18,000,000
Element Science

San Francisco, California, United States

Element Science is a medical device and digital health start-up that develops lifesaving wearable solutions.

BiotechnologyHealth CareMedicalMedical DeviceWearables
Series AMar 19, 2014
Amount Raised: $12,500,000
NinePoint Medical

Cambridge, Massachusetts, United States

NinePoint Medical is a transformational medical device company developing innovative, real-time, in vivo pathology devices.

Health CareMedicalMedical Device
Series BMar 18, 2014
Amount Raised: $34,000,000
NGM Biopharmaceuticals

South San Francisco, California, United States

NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.

BiopharmaBiotechnologyGeneticsMedical
Series CJul 18, 2013
Amount Raised: $50,000,000
SentreHEART

Redwood City, California, United States

SentreHEART is a medical device company developing tissue closure solutions, offering physicians control over remotely delivered sutures.

Health CareMedicalMedical Device
Series CJun 4, 2012
Amount Raised: $26,000,000
Satori Pharmaceuticals

Cambridge, Massachusetts, United States

Satori Pharmaceuticals develops disease-modifying therapies for alzheimer's, parkinson's and other neurodegenerative disorders.

Health CareNeurosciencePharmaceutical
Series UnknownFeb 23, 2012
Amount Raised: $15,000,000
DFine

San Jose, California, United States

DFine is a medical device company that develops therapeutic devices to manage compression fractures of the spine.

Health CareMedical DeviceTherapeutics
Series UnknownNov 8, 2011
Amount Raised: $25,000,000
Topica Pharmaceuticals

Palo Alto, California, United States

TOPICA Pharmaceuticals is a clinical research stage company focused on developing topical treatment for fungal infections of the nail.

BiotechnologyMedical DevicePharmaceutical
Series BOct 18, 2011
Amount Raised: $27,000,000